StemSTEM
STEM
About: Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
Employees: 569
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
133% more call options, than puts
Call options by funds: $413K | Put options by funds: $177K
94% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 16
9% more funds holding
Funds holding: 141 [Q4 2024] → 153 (+12) [Q1 2025]
3.5% less ownership
Funds ownership: 31.49% [Q4 2024] → 27.99% (-3.5%) [Q1 2025]
12% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 43
48% less capital invested
Capital invested by funds: $30.9M [Q4 2024] → $16.1M (-$14.8M) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$0.60
32%
upside
Avg. target
$0.60
32%
upside
High target
$0.60
32%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Susquehanna Biju Perincheril | 32%upside $0.60 | Neutral Maintained | 1 May 2025 |
Financial journalist opinion
Based on 6 articles about STEM published over the past 30 days
Neutral
Business Wire
2 days ago
Stem PowerTrack™ Scales Norbut Solar Farms' Community Solar Development and EPC Growth
HOUSTON--(BUSINESS WIRE)--Stem (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that Norbut Solar Farms (NSF), a leading community solar developer in the New York ISO (NYISO) power market, will standardize on Stem's PowerTrack™ software to scale and manage its growing portfolio of solar projects. The collaboration will enable NSF to accelerate its Engineering, Procurement, and Construction (EPC) strategy, bringing more clean energy projects online.
Neutral
Business Wire
3 days ago
Stem, Inc. Announces 1-for-20 Reverse Stock Split
HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM) (the “Company” or “Stem”) today announced that it will implement a 1-for-20 reverse stock split of the issued and outstanding shares of the Company's common stock, effective at 12:01 a.m. Eastern Time on June 23, 2025 (the “Effective Time”), in order to regain compliance with the minimum average closing price requirement under the rules of the New York Stock Exchange (the “NYSE”). The Company's common stock is expected to begin trading on a reve.
Neutral
Business Wire
1 week ago
Stem Announces Support of One of Nation's Largest Solar-Plus-Storage Projects
SAN FRANCISCO--(BUSINESS WIRE)--Stem (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced its role in the engineering advisory and design support of Green River Energy Center. Stem's services for the project include energy storage metering configuration, review of power flow scenarios, and auxiliary load assumptions. Developed and indirectly owned by rPlus Energies and situated in Eastern Utah, this transformative 400-megawatt (MW) solar and 1,600-mega.
Neutral
GlobeNewsWire
2 weeks ago
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Second Oncology Candidate (VTX-0P4) in a Prostate Stem Cell Antigen (PSCA) Related Tumor Study in Combination with a Checkpoint Inhibitor (CPI) / anti-mPD-1
Study conducted at The Massachusetts General Hospital's Vaccine and Immunotherapy Center demonstrated highly significant improvements in Overall Survival and other key endpoints VTX-0P4, in combination with a CPI, had a statistically significant improvement in survival versus a CPI alone Key targets include Urothelial, Prostate, and Renal Cancers VTX-0P4 produced a safety profile similar to that seen in the control group and without evidence of reactogenicity NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc., a Lucius Partners portfolio company, announced today that data from Study VTX-IO-004 demonstrated clear proof-of concept for the self-assembling therapeutic, VTX-0P4, in the treatment of cancers over-expressing prostate stem cell antigen (PSCA). VTX-0P4 is a novel, modular, protein-based therapy candidate designed to provide a specific therapeutic T cell mediated immunogenic response to PSCA-expressing tumors.
Negative
Zacks Investment Research
3 weeks ago
Bears are Losing Control Over Stem (STEM), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for Stem (STEM), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Positive
Zacks Investment Research
3 weeks ago
Stem Jumps 32% in a Month: Should You Add the Stock to Your Portfolio?
STEM's performance shines with a record cash flow, margin expansion and software-led growth, setting the stage for a profitable 2025.
Positive
Zacks Investment Research
1 month ago
Here Is Why Bargain Hunters Would Love Fast-paced Mover Stem (STEM)
Stem (STEM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Positive
Zacks Investment Research
1 month ago
Renewable Energy & Battery Storage Stocks to Add to Your Portfolio Now
As industries are increasingly adopting renewable energy, demand for energy storage solutions is surging. You may consider buying DTE, BEP, BE & STEM.
Negative
Zacks Investment Research
1 month ago
Stem, Inc. (STEM) Reports Q1 Loss, Tops Revenue Estimates
Stem, Inc. (STEM) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.46 per share a year ago.
Neutral
Seeking Alpha
1 month ago
Stem, Inc. (STEM) Q1 2025 Earnings Call Transcript
Stem, Inc. (NYSE:STEM ) Q1 2025 Earnings Conference Call April 29, 2025 5:00 PM ET Company Participants Ted Durbin - Head, IR Arun Narayanan - CEO Doran Hole - CFO and EVP Conference Call Participants Justin Clare - ROTH Capital Partners Thomas Boyes - TD Cowen Dylan Nassano - Wolfe Research Operator Greetings, and welcome to the Stem, Inc. First Quarter 2025 Results Conference Call. At this time, all participants are in listen-only mode.
Charts implemented using Lightweight Charts™